Lipase Inhibitors [MoA] - N0000009916
Pharmacologic Class Information
Pharmacologic Code | N0000009916 |
Pharmacologic Name | Lipase Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Lipase Inhibitors
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Lipase Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0135-0461 | Alli | Non-Proprietary Name: Orlistat | Capsule | Oral | Haleon Us Holdings Llc | ACTIVE | |
61269-460 | Xenical | Non-Proprietary Name: Orlistat | Capsule | Oral | H2-pharma Llc | ACTIVE | |
61269-565 | Orlistat | Non-Proprietary Name: Orlistat | Capsule | Oral | H2-pharma Llc | ACTIVE | |
71610-805 | Alli | Non-Proprietary Name: Orlistat | Capsule | Oral | Aphena Pharma Solutions - Tennessee, Llc | ACTIVE |